Cargando…
Mapping the immune landscape in small cell lung cancer by analysing expression of immuno-modulators in tissue biopsies and paired blood samples
Small cell lung carcinomas (SCLC) are aggressive tumors with high propensity to metastasize. Recent NCCN guidelines have incorporated immunotherapy in extensive stage SCLC. Limited benefit in few patients compounded by side effects of unwonted immune-checkpoint-inhibitor (ICPI) usage necessitates id...
Autores principales: | Dutta, Rimlee, Rathor, Amber, Sharma, Hanuman Prasad, Pandey, Hem Chandra, Malik, Prabhat Singh, Mohan, Anant, Nambirajan, Aruna, Kumar, Rajeev, Jain, Deepali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988882/ https://www.ncbi.nlm.nih.gov/pubmed/36879122 http://dx.doi.org/10.1038/s41598-023-30841-3 |
Ejemplares similares
-
Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non–small cell lung carcinoma
por: Nakra, Tripti, et al.
Publicado: (2021) -
Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review
por: Singh, Priyanka, et al.
Publicado: (2022) -
Massive biventricular rhabdomyoma in a neonate
por: Pandey, Manish, et al.
Publicado: (2017) -
Immuno-genomic landscape of osteosarcoma
por: Wu, Chia-Chin, et al.
Publicado: (2020) -
Comparison of laboratory-developed test & validated assay of programmed death ligand-1 immunohistochemistry in non-small-cell lung carcinoma
por: Nambirajan, Aruna, et al.
Publicado: (2019)